about
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonistCR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats.Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.Simultaneous monitoring of cytosolic free calcium and exocytosis at the single cell levelCR4056, a powerful analgesic imidazoline-2 receptor ligand, inhibits the inflammation-induced PKCε phosphorylation and membrane translocation in sensory neurons
P50
description
researcher
@en
name
O Letari
@en
O Letari
@nl
type
label
O Letari
@en
O Letari
@nl
prefLabel
O Letari
@en
O Letari
@nl
P106
P31
P496
0000-0002-5807-3937